Table 2.
Distribution of preexisting medical conditions (ITT population)
| Medical condition | Treatment group | Overall N = 161 | |
|---|---|---|---|
| s‐NPWT N = 80 | t‐NPWT N = 81 | ||
| Anemia | 13 (16.3%) | 12 (14.8%) | 25 (15.5) |
| Stroke (CVA) | 5 (6.3%) | 6 (7.4%) | 11 (6.8%) |
| Peripheral vascular disease | 14 (17.5%) | 10 (12.3%) | 24 (14.9%) |
| Congestive heart failure | 7 (8.8%) | 13 (16%) | 20 (12.4%) |
| Rheumatoid arthritis | 2 (2.5%) | 4 (4.9%) | 6 (3.7%) |
| Osteoarthritis | 15 (18.8%) | 17 (21%) | 32 (19.9%) |
| Deep vein thrombosis | 9 (11.3%) | 13 (16%) | 22 (13.7%) |
| Varicose veins | 22 (27.5%) | 29 (35.8%) | 51 (31.7%) |
| Immunodeficiency | 1 (1.3%) | 2 (2.5%) | 3 (1.9%) |
| Steroid use | 1 (1.3%) | 1 (1.2%) | 2 ((1.2%) |
| Hypertension | 59 (73.8%) | 54 (66.7%) | 113 (70.2%) |
| Neuropathy | 38 (47.5%) | 42 (51.9%) | 80 (49.7%) |